Peijia Medical announces financial results for the six-month period ending June 30.
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Aug 25 2025
0mins
Should l Buy ?
Source: SeekingAlpha
Financial Performance: Peijia Medical reported a net loss of RMB30.7 million for the six months ended June 30, marking a 52.4% reduction compared to the previous period, excluding losses from Future Technology Business.
Revenue Growth: The company's revenue increased by 17.3% year-over-year, reaching RMB353.4 million.
Core Business Focus: The financial results highlight improvements in the core business operations, despite challenges faced by other segments.
Market Context: This financial update provides insight into Peijia Medical's performance amidst ongoing developments in the medical technology sector.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
